|
|
Article: SMITHKLINE BEECHAM'S AUGMENTIN(R) CLEARED IN U.S. IN MORE CONVENIENT DOSING REGIMEN FOR CHILDREN
- Article from:
- PR Newswire
- Article date:
- June 3, 1996
CopyrightCOPYRIGHT 1996 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Twice-A-Day Regimen and New Formulations Reduce the Most Troublesome
Side Effect of Drug Widely Used in Fight Against Resistant Bacteria
New Fruit Flavors, Too
PHILADELPHIA, June 3 /PRNewswire/ -- SmithKline Beecham (SB) (NYSE: SBH) announced today that it has received U.S. marketing clearance for a more convenient pediatric dosing regimen of Augmentin amoxicillin/clavulanate potassium), one of the most frequently used antibiotics for infections involving drug-resistant bacteria. Also cleared were new pediatric formulations in new dosage strengths.
The new, twice-daily (BID) pediatric dosing schedule provides the same ...